tenk.fyi

GYRE THERAPEUTICS, INC.

GYRENasdaq· Pharmaceutical Preparations

Price History

Revenue

$116.6M

10.2% YoY

Net Income

$9.9M

44.8% YoY

EPS

$0.02

60.0% YoY

Cash

$37.1M

213.8% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.

Upgrade to Pro